Back

Implantable cardioverter-defibrillator implantation in incidental Brugada Syndrome diagnosed after treatment with sodium channel-blocker

8 April 2024 (10:30 - 10:39)
Organised by: Logo
Congress Presentation Part of: Sudden cardiac death scenarios Clinical EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sofia Jacinto

Hospital de Santa Marta, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail
Complex management of acute myocardial infarction in a high-risk brazilian traveler: utilizing a wearable cardioverter defibrillator for long-haul flight safety
Doctor V. Buia (Fuerth, DE)
Slides Video
Presentation thumbnail
Implantable cardioverter defibrillator for primary prevention in arrhythmic mitral valve prolapse: a shocking choice?
Doctor R. Pittorru (Barcelona, ES)
Slides Video
Presentation thumbnail
A tale of two sisters with long QT syndrome
Doctor M. Mohamed (Coventry, GB)
Slides Video
Presentation thumbnail
A young woman with aborted sudden cardiac death and refractory vasospastic angina
Doctor A. Bozorgi (Tehran, IR)
Slides Video

Access the full session

Session thumbnail
Sudden cardiac death scenarios

The Event

Event poster

EHRA 2024

8 April 2024 10:30 CET
You may be interested in
thumbnail
Congress Presentation
TYPE I BRUGADA PATTERN IN INFERIOR LEADS OF THE EKG AS A RESULT OF AN AJMALINE TEST
thumbnail
Congress Presentation
The great dilemma: type-1 Brugada ECG pattern or right bundle branch block?
thumbnail
Congress Presentation
Unmasking Brugada syndrome: diagnostic oversights case

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources